Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors

NCT07523529 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Unresectable
Metastatic

Interventions

BIOLOGICAL: Autologous dual-target CAR-T cells selected from the predefined target library.
DRUG: Fludarabine
DRUG: Cyclophosphamide

Sponsor

Beijing Biotech